Skip to Main Content

Paper Details

Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.
Eur Heart J Cardiovasc Pharmacother
4
2022
CAD, Diabetes Mellitus, MI, Patients, T2DM, THEMIS, Ticagrelor, aspirin, coronary artery disease, myocardial infarction, patient, patients, stroke, ticagrelor, type 2 diabetes
Author NameAffiliation
Deepak L BhattBrigham and Women's Hospital Heart and Vascular Center and Harvard Medical School
Robert A HarringtonStanford University
  • 1 - 2

Datasets

Release 1.2